Moscow, December 24, 2013 – Pharmstandard OJSC (“Pharmstandard” or the “Company”), a leading pharmaceutical company in Russia, announces that it has completed the reorganization of the Company by spin-off of OTCPharm PJSC (“OTCPharm”). The date of State Registration is December 23, 2013.

OTC shares are to be distributed to all shareholders at the date of OTCPharm registration in proportion ¼, i.e. 1 Pharmstandard ordinary share = 4 OTCPharm ordinary shares.

Trading activities on MOEX will be resumed as per MOEX listing rules.

Additional information will be available shortly in a presentation on Pharmstandard web-site (https://pharmstd.com/page_6.html) and on OTCPharm website (only russian version) (https://otcpharm.ru/investors/presentation/).

Contacts:

Irina Bakhturina
Head of Investor Relations

Pharmstandard OJSC

+7 495 970 00 30 ext.2824

www.pharmstd.com